SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-169207

Patient #041

Yap Cheng Hong · 55y · Male · Chinese · BMI 26.6 · ECOG 1
SVMC - Sunway Velocity · Cardiothoracic Surgery · Dr. Ng Wei Sheng
IA2 (T1b, N0)Disease-free
KRAS G12C
Clinical storyline

Yap Cheng Hong, a 55-year-old Chinese male (former, 33 pack-years, ECOG 1), presented in 2025-10 with unintentional weight loss (~5kg over 3 months). Workup confirmed Adenocarcinoma (Stage I, KRAS G12C). The MDT recommended curative-intent surgery. Current status: Disease-free.

HPE Results
Well-differentiated adenocarcinoma, acinar, no invasion, stage IA (T1b, N0, Mx)
Clinical Stage
IA2 (T1b, N0)
Pathological Stage
IA2 (T1b, N0, Mx)
Adenocarcinoma Subtype
Acinar
CEA (ng/mL)
4.2
Tumor (CT/PET)
2 cm
PET SUV
0
NGS Results
KRAS G12C mutation